“Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma”. Journal of Kidney Cancer, vol. 5, no. 4, Oct. 2018, pp. 6-13, https://doi.org/10.15586/jkcvhl.2018.107.